Opiodur (Fentanyl)

Fentanyl, the active ingredient in Opiodur, is an opioid analgesic presented as a transdermal patch for systemic use. It treats severe chronic pain in patients who require continuous, long‑term opioid therapy and who are opioid‑tolerant. GNH USA supplies Opiodur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Opiodur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Opiodur is an opioid analgesic that acts on the central nervous system to manage severe pain conditions.

- Cancer‑related pain: provides continuous opioid analgesia for patients with breakthrough pain despite other therapies. - Post‑surgical pain: offers sustained pain relief during the postoperative recovery period when oral opioids are insufficient. - Chronic non‑cancer pain: delivers long‑acting analgesia for conditions such as severe osteoarthritis or neuropathic pain in opioid‑tolerant individuals. - Palliative‑care pain: maintains comfort in end‑of‑life care where stable plasma levels are required. - Acute severe trauma trauma: stabilizes pain levels in patients with major injuries awaiting definitive treatment.

Adverse reactions to fentanyl may vary in frequency and severity.

Common Side Effects: - Nausea: mild to moderate upset stomach often reported. - Constipation: reduced bowel motility leading to hard stools. - Drowsiness: increased sleepiness or reduced alertness. - Dizziness: sensation of light‑headedness or imbalance. - Dry mouth: reduced salivation causing a parched feeling. - Itching: mild skin pruritus at the application site.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing faintness. - Cardiac arrest: sudden loss of heart function. - Anaphylaxis: severe allergic reaction with hives, swelling, and airway compromise. - Seizures: convulsive episodes in susceptible individuals. - Local skin necrosis: tissue death at the patch site.

When using Opiodur, careful monitoring and adherence to safety guidelines are essential.

- Titration: adjust dose gradually under medical supervision to avoid overdose. - Opioid tolerance: confirm patient is opioid‑tolerant before initiating therapy. - Respiratory monitoring: watch for signs of slowed breathing, especially after dose changes. - Concomitant CNS depressants: avoid or limit use with alcohol, benzodiazepines, or other sedatives. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Fentanyl may interact with several other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): can increase fentanyl plasma levels and risk of respiratory depression. - CNS depressants (e.g., benzodiazepines, barbiturates, alcohol): additive sedation and respiratory depression. - MAO inhibitors: may precipitate severe hypotension or serotonin syndrome.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce fentanyl concentrations, decreasing analgesic effect. - Anticholinergic agents: can worsen constipation. - Diuretics: may enhance hypotensive effects.